Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor

Compositions and methods for reactivating latent immunodeficiency virus using a GSK-3 inhibitor

US Patent 11590110 · Granted Feb 28, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric protein comprising an anti-influenza virus antibody moiety and a mucoad2025
Compositions for preventing or treating coronavirus infections2025
Animal model for SARS-CoV-2-spike induced coagulopathy2024
Modified non-natural NKG2D ligands that selectively deliver attached heterologou2022
Treatment of HIV-1 infection and AIDS2018
Treatment of HIV-1 infection and AIDS2016
Methods for treating lentivirus infections2012
Methods and compositions for the synergistic activation of latent HIV2012
Methods for treating lentivirus infections2010
Virion-based fusion assay2007
Methods of identifying agents for inhibiting lentivirus replication2006
Methods for identifying modulators of NF-KB activity2006